Status:
COMPLETED
Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
16+ years
Brief Summary
There are very few studies comparing the accuracy, sensitivity and specificity of HemoCue glucose 201 RT system with the laboratory gold standard. The incidence of cystic fibrosis related diabetes (C...
Detailed Description
All CF patients attending annual review who require an OGTT will have a venous and a capillary blood sample taken simultaneously before (fasting = 0 min) and 2 hours (post glucose load = 120 min) afte...
Eligibility Criteria
Inclusion
- The first 70 consecutive suitable consenting adult CF patients, who are 16 years of age and over, attending annual review at the Royal Brompton Hospital from June 2013 to March 2014, are eligible for the study
Exclusion
- Patients with an existing diagnosis of CFRD are exclude.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01883037
Start Date
June 1 2013
End Date
May 1 2014
Last Update
November 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton Hospital
London, United Kingdom, SW3 6NP